NF45/NF90‐mediated rDNA transcription provides a novel target for immunosuppressant development

Abstract Herein, we demonstrate that NFAT, a key regulator of the immune response, translocates from cytoplasm to nucleolus and interacts with NF45/NF90 complex to collaboratively promote rDNA transcription via triggering the directly binding of NF45/NF90 to the ARRE2‐like sequences in rDNA promoter...

Full description

Saved in:
Bibliographic Details
Main Authors: Hsiang‐i Tsai, Xiaobin Zeng, Longshan Liu, Shengchang Xin, Yingyi Wu, Zhanxue Xu, Huanxi Zhang, Gan Liu, Zirong Bi, Dandan Su, Min Yang, Yijing Tao, Changxi Wang, Jing Zhao, John E Eriksson, Wenbin Deng, Fang Cheng, Hongbo Chen
Format: Article
Language:English
Published: Springer Nature 2021-02-01
Series:EMBO Molecular Medicine
Subjects:
Online Access:https://doi.org/10.15252/emmm.202012834
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1849234641660149760
author Hsiang‐i Tsai
Xiaobin Zeng
Longshan Liu
Shengchang Xin
Yingyi Wu
Zhanxue Xu
Huanxi Zhang
Gan Liu
Zirong Bi
Dandan Su
Min Yang
Yijing Tao
Changxi Wang
Jing Zhao
John E Eriksson
Wenbin Deng
Fang Cheng
Hongbo Chen
author_facet Hsiang‐i Tsai
Xiaobin Zeng
Longshan Liu
Shengchang Xin
Yingyi Wu
Zhanxue Xu
Huanxi Zhang
Gan Liu
Zirong Bi
Dandan Su
Min Yang
Yijing Tao
Changxi Wang
Jing Zhao
John E Eriksson
Wenbin Deng
Fang Cheng
Hongbo Chen
author_sort Hsiang‐i Tsai
collection DOAJ
description Abstract Herein, we demonstrate that NFAT, a key regulator of the immune response, translocates from cytoplasm to nucleolus and interacts with NF45/NF90 complex to collaboratively promote rDNA transcription via triggering the directly binding of NF45/NF90 to the ARRE2‐like sequences in rDNA promoter upon T‐cell activation in vitro. The elevated pre‐rRNA level of T cells is also observed in both mouse heart or skin transplantation models and in kidney transplanted patients. Importantly, T‐cell activation can be significantly suppressed by inhibiting NF45/NF90‐dependent rDNA transcription. Amazingly, CX5461, a rDNA transcription‐specific inhibitor, outperformed FK506, the most commonly used immunosuppressant, both in terms of potency and off‐target activity (i.e., toxicity), as demonstrated by a series of skin and heart allograft models. Collectively, this reveals NF45/NF90‐mediated rDNA transcription as a novel signaling pathway essential for T‐cell activation and as a new target for the development of safe and effective immunosuppressants.
format Article
id doaj-art-a63fdeff89ba40b9b30a6caeff5ad0b3
institution Kabale University
issn 1757-4676
1757-4684
language English
publishDate 2021-02-01
publisher Springer Nature
record_format Article
series EMBO Molecular Medicine
spelling doaj-art-a63fdeff89ba40b9b30a6caeff5ad0b32025-08-20T04:03:06ZengSpringer NatureEMBO Molecular Medicine1757-46761757-46842021-02-0113311810.15252/emmm.202012834NF45/NF90‐mediated rDNA transcription provides a novel target for immunosuppressant developmentHsiang‐i Tsai0Xiaobin Zeng1Longshan Liu2Shengchang Xin3Yingyi Wu4Zhanxue Xu5Huanxi Zhang6Gan Liu7Zirong Bi8Dandan Su9Min Yang10Yijing Tao11Changxi Wang12Jing Zhao13John E Eriksson14Wenbin Deng15Fang Cheng16Hongbo Chen17School of Pharmaceutical Sciences (Shenzhen), Sun Yat‐Sen UniversityCenter Lab of Longhua Branch and Department of Infectious Disease, Shenzhen People's Hospital, 2nd Clinical Medical College of Jinan UniversityOrgan Transplant Centerm, The First Affiliated Hospital, Sun Yat‐sen UniversityState Key Laboratory of Coordination Chemistry, Institute of Chemistry and Biomedical Sciences, School of Life Sciences, Nanjing UniversitySchool of Pharmaceutical Sciences (Shenzhen), Sun Yat‐Sen UniversitySchool of Pharmaceutical Sciences (Shenzhen), Sun Yat‐Sen UniversityOrgan Transplant Centerm, The First Affiliated Hospital, Sun Yat‐sen UniversitySchool of Pharmaceutical Sciences (Shenzhen), Sun Yat‐Sen UniversityOrgan Transplant Centerm, The First Affiliated Hospital, Sun Yat‐sen UniversitySchool of Pharmaceutical Sciences (Shenzhen), Sun Yat‐Sen UniversitySchool of Pharmaceutical Sciences (Shenzhen), Sun Yat‐Sen UniversitySchool of Pharmaceutical Sciences (Shenzhen), Sun Yat‐Sen UniversityOrgan Transplant Centerm, The First Affiliated Hospital, Sun Yat‐sen UniversityState Key Laboratory of Coordination Chemistry, Institute of Chemistry and Biomedical Sciences, School of Life Sciences, Nanjing UniversityCell Biology, Biosciences, Faculty of Science and Engineering, Åbo Akademi UniversitySchool of Pharmaceutical Sciences (Shenzhen), Sun Yat‐Sen UniversitySchool of Pharmaceutical Sciences (Shenzhen), Sun Yat‐Sen UniversitySchool of Pharmaceutical Sciences (Shenzhen), Sun Yat‐Sen UniversityAbstract Herein, we demonstrate that NFAT, a key regulator of the immune response, translocates from cytoplasm to nucleolus and interacts with NF45/NF90 complex to collaboratively promote rDNA transcription via triggering the directly binding of NF45/NF90 to the ARRE2‐like sequences in rDNA promoter upon T‐cell activation in vitro. The elevated pre‐rRNA level of T cells is also observed in both mouse heart or skin transplantation models and in kidney transplanted patients. Importantly, T‐cell activation can be significantly suppressed by inhibiting NF45/NF90‐dependent rDNA transcription. Amazingly, CX5461, a rDNA transcription‐specific inhibitor, outperformed FK506, the most commonly used immunosuppressant, both in terms of potency and off‐target activity (i.e., toxicity), as demonstrated by a series of skin and heart allograft models. Collectively, this reveals NF45/NF90‐mediated rDNA transcription as a novel signaling pathway essential for T‐cell activation and as a new target for the development of safe and effective immunosuppressants.https://doi.org/10.15252/emmm.202012834CX5461NF45/NF90NFATnucleolusorgan transplantation
spellingShingle Hsiang‐i Tsai
Xiaobin Zeng
Longshan Liu
Shengchang Xin
Yingyi Wu
Zhanxue Xu
Huanxi Zhang
Gan Liu
Zirong Bi
Dandan Su
Min Yang
Yijing Tao
Changxi Wang
Jing Zhao
John E Eriksson
Wenbin Deng
Fang Cheng
Hongbo Chen
NF45/NF90‐mediated rDNA transcription provides a novel target for immunosuppressant development
EMBO Molecular Medicine
CX5461
NF45/NF90
NFAT
nucleolus
organ transplantation
title NF45/NF90‐mediated rDNA transcription provides a novel target for immunosuppressant development
title_full NF45/NF90‐mediated rDNA transcription provides a novel target for immunosuppressant development
title_fullStr NF45/NF90‐mediated rDNA transcription provides a novel target for immunosuppressant development
title_full_unstemmed NF45/NF90‐mediated rDNA transcription provides a novel target for immunosuppressant development
title_short NF45/NF90‐mediated rDNA transcription provides a novel target for immunosuppressant development
title_sort nf45 nf90 mediated rdna transcription provides a novel target for immunosuppressant development
topic CX5461
NF45/NF90
NFAT
nucleolus
organ transplantation
url https://doi.org/10.15252/emmm.202012834
work_keys_str_mv AT hsiangitsai nf45nf90mediatedrdnatranscriptionprovidesanoveltargetforimmunosuppressantdevelopment
AT xiaobinzeng nf45nf90mediatedrdnatranscriptionprovidesanoveltargetforimmunosuppressantdevelopment
AT longshanliu nf45nf90mediatedrdnatranscriptionprovidesanoveltargetforimmunosuppressantdevelopment
AT shengchangxin nf45nf90mediatedrdnatranscriptionprovidesanoveltargetforimmunosuppressantdevelopment
AT yingyiwu nf45nf90mediatedrdnatranscriptionprovidesanoveltargetforimmunosuppressantdevelopment
AT zhanxuexu nf45nf90mediatedrdnatranscriptionprovidesanoveltargetforimmunosuppressantdevelopment
AT huanxizhang nf45nf90mediatedrdnatranscriptionprovidesanoveltargetforimmunosuppressantdevelopment
AT ganliu nf45nf90mediatedrdnatranscriptionprovidesanoveltargetforimmunosuppressantdevelopment
AT zirongbi nf45nf90mediatedrdnatranscriptionprovidesanoveltargetforimmunosuppressantdevelopment
AT dandansu nf45nf90mediatedrdnatranscriptionprovidesanoveltargetforimmunosuppressantdevelopment
AT minyang nf45nf90mediatedrdnatranscriptionprovidesanoveltargetforimmunosuppressantdevelopment
AT yijingtao nf45nf90mediatedrdnatranscriptionprovidesanoveltargetforimmunosuppressantdevelopment
AT changxiwang nf45nf90mediatedrdnatranscriptionprovidesanoveltargetforimmunosuppressantdevelopment
AT jingzhao nf45nf90mediatedrdnatranscriptionprovidesanoveltargetforimmunosuppressantdevelopment
AT johneeriksson nf45nf90mediatedrdnatranscriptionprovidesanoveltargetforimmunosuppressantdevelopment
AT wenbindeng nf45nf90mediatedrdnatranscriptionprovidesanoveltargetforimmunosuppressantdevelopment
AT fangcheng nf45nf90mediatedrdnatranscriptionprovidesanoveltargetforimmunosuppressantdevelopment
AT hongbochen nf45nf90mediatedrdnatranscriptionprovidesanoveltargetforimmunosuppressantdevelopment